Comparing Herceptin vs Kanjinti
| Herceptin (trastuzumab) | Kanjinti (trastuzumab) |
|
|---|
| Herceptin (trastuzumab) | Kanjinti (trastuzumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Breast Cancer - Adjuvant, Breast Cancer, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer. Herceptin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer - Adjuvant, Breast Cancer, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer. Kanjinti may also be used for purposes not listed in this medication guide. |
Related suggestions Breast Cancer
Breast Cancer, Adjuvant
Esophageal Carcinoma
Popular comparisons
|
|||||||||||||||
| More about Herceptin (trastuzumab) | More about Kanjinti (trastuzumab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Herceptin has an average rating of 8.5 out of 10 from a total of 12 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Herceptin side effects |
View all Kanjinti side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Herceptin prices |
View all Kanjinti prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other trastuzumab brands include: Hercessi, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera | Other trastuzumab brands include: Herceptin, Hercessi, Herzuma, Ogivri, Ontruzant, Trazimera | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
924 hours |
924 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 192 drugs are known to interact with Herceptin:
|
A total of 192 drugs are known to interact with Kanjinti:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
September 25, 1998 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.